Global surveillance of oral tobacco products : total nicotine, unionised nicotine and tobacco-specific N-nitrosamines

Show simple item record

dc.contributor.author Stanfill, Stephen B.
dc.contributor.author Connolly, Gregory N.
dc.contributor.author Zhang, Liqin
dc.contributor.author Jia, Lily T.
dc.contributor.author Henningfield, Jack E.
dc.contributor.author Richter, Patricia
dc.contributor.author Lawler, Tameka S.
dc.contributor.author Ayo-Yusuf, Olalekan Abdulwahab
dc.contributor.author Ashley, David L.
dc.contributor.author Watson, Clifford H.
dc.date.accessioned 2011-08-19T10:14:33Z
dc.date.available 2011-08-19T10:14:33Z
dc.date.issued 2011-06-22
dc.description.abstract OBJECTIVE: Oral tobacco products contain nicotine and carcinogenic tobacco-specific N-nitrosamines (TSNAs) that can be absorbed through the oral mucosa. The aim of this study was to determine typical pH ranges and concentrations of total nicotine, unionised nicotine (the most readily absorbed form) and five TSNAs in selected oral tobacco products distributed globally. METHODS: A total of 53 oral tobacco products from 5 World Health Organisation (WHO) regions were analysed for total nicotine and TSNAs, including 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanol (NNAL), using gas chromatography or liquid chromatography with mass spectrometric detection. Unionised nicotine concentrations were calculated using product pH and total nicotine concentrations. Fourier transform infrared spectroscopy was used to help categorise or characterise some products. RESULTS: Total nicotine content varied from 0.16 to 34.1 mg/g product, whereas, the calculated unionised nicotine ranged from 0.05 to 31.0 mg/g product; a 620-fold range of variation. Products ranged from pH 5.2 to 10.1, which translates to 0.2% to 99.1% of nicotine being in the unionised form. Some products have very high pH and correspondingly high unionised nicotine (eg, gul powder, chimo´, toombak) and/or high TSNA (eg, toombak, zarda, khaini) concentrations. The concentrations of TSNAs spanned five orders of magnitude with concentrations of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) ranging from 4.5 to 516 000 ng/g product. CONCLUSIONS: These data have important implications for risk assessment because they show that very different exposure risks may be posed through the use of these chemically diverse oral tobacco products. Because of the wide chemical variation, oral tobacco products should not be categorised together when considering the public health implications of their use. en_US
dc.description.sponsorship This work was funded by the U.S. Government, Department of Health and Human Services. This study was also funded internally at the Centers for Disease Control and Prevention, with funds directly provided by the U.S. federal government. en_US
dc.description.uri http://tobaccocontrol.bmj.com/ en
dc.identifier.citation Stanfill, SB, Connolly, GN, Zhang, L, Jia, LT, Henningfield, JE, Richter, P, Lawler, TS, Ayo-Yusuf, OA, Ashley, DL & Watson, CH 2011, 'Global surveillance of oral tobacco products : total nicotine, unionised nicotine and tobacco-specific N-nitrosamines', Tobacco Control, vol. 20, no. 3, pp. 1-10. en_US
dc.identifier.issn 0964-4563 (print)
dc.identifier.issn 1468-3318 (online)
dc.identifier.other 10.1136/tc.2010.037465
dc.identifier.uri http://hdl.handle.net/2263/17086
dc.language.iso en en_US
dc.publisher BMJ en_US
dc.rights BMJ en_US
dc.subject Oral tobacco products en_US
dc.subject.lcsh Nicotine -- Research en
dc.subject.lcsh
dc.title Global surveillance of oral tobacco products : total nicotine, unionised nicotine and tobacco-specific N-nitrosamines en
dc.type Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record